{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:14:18Z","timestamp":1795061658382,"version":"4.10.2"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.survophthal.2025.09.025","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T23:07:59Z","timestamp":1759360079000},"page":"1188-1195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prefilled syringes and post-intravitreal injection endophthalmitis: A network meta-analysis"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7069-3162","authenticated-orcid":false,"given":"Brendan K.","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mihalache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim S.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko M.","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parampal","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kertes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Kherani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Tennant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo V.","family":"Navajas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Ching","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev H.","family":"Muni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3818-9788","authenticated-orcid":false,"given":"Peng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.survophthal.2025.09.025_bib1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/IAE.0000000000003748","article-title":"Clinical outcomes of acute endophthalmitis after intravitreal delivery of vascular endothelial growth factor inhibitors versus steroids","volume":"43","author":"Adams","year":"2023","journal-title":"RETINA"},{"issue":"12","key":"10.1016\/j.survophthal.2025.09.025_bib2","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamaophthalmol.2018.3939","article-title":"Association of acute endophthalmitis with intravitreal injections of corticosteroids or Anti\u2013Vascular growth factor agents in a nationwide study in France","volume":"136","author":"Baudin","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2025.09.025_bib3","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1097\/IAE.0000000000002351","article-title":"Comparative risk of endophthalmitis after intravitreal injection with bevacizumab, aflibercept, and ranibizumab","volume":"39","author":"Bavinger","year":"2019","journal-title":"RETINA"},{"issue":"4","key":"10.1016\/j.survophthal.2025.09.025_bib4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/IAE.0000000000000392","article-title":"Eliminating antibiotic prophylaxis for intravitreal injections: a consecutive series of 18,839 injections by a single surgeon","volume":"35","author":"Bhavsar","year":"2015","journal-title":"RETINA"},{"issue":"3","key":"10.1016\/j.survophthal.2025.09.025_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/09273948.2020.1820530","article-title":"Does pharmaceutical compounding of vascular endothelial growth factor inhibitors for intravitreal use alter the risk of Post-injection endophthalmitis?","volume":"30","author":"Blom","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2025.09.025_bib6","doi-asserted-by":"crossref","first-page":"m3907","DOI":"10.1136\/bmj.m3907","article-title":"GRADE approach to drawing conclusions from a network meta-analysis using a partially contextualised framework","volume":"371","author":"Brignardello-Petersen","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.survophthal.2025.09.025_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9212524","article-title":"Postintravitreal injection endophthalmitis: incidence, characteristics, management, and outcome","volume":"2023","author":"Davidov","year":"2023","journal-title":"J Ophthalmol"},{"issue":"10347","key":"10.1016\/j.survophthal.2025.09.025_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(22)00878-9","article-title":"Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis","volume":"400","author":"De Crescenzo","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.survophthal.2025.09.025_bib9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3928\/23258160-20210528-03","article-title":"Rates of suspected endophthalmitis following intravitreal injections in clinical practices in the United States","volume":"52","author":"Dhoot","year":"2021","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"16","key":"10.1016\/j.survophthal.2025.09.025_bib10","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1002\/sim.8158","article-title":"Network meta-analysis of rare events using the Mantel-Haenszel method","volume":"38","author":"Efthimiou","year":"2019","journal-title":"Stat Med"},{"key":"10.1016\/j.survophthal.2025.09.025_bib11","unstructured":"FDA Approves Genentech\u2019s Lucentis\u00ae (Ranibizumab Injection) Prefilled Syringe. Vol. 2024, Genentech, 2016."},{"issue":"4","key":"10.1016\/j.survophthal.2025.09.025_bib12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/24741264231159011","article-title":"Reduced incidence of intravitreal Injection\u2013Related endophthalmitis with prefilled syringes","volume":"7","author":"Feng","year":"2023","journal-title":"J Vitreoretina Dis"},{"issue":"1","key":"10.1016\/j.survophthal.2025.09.025_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000518236","article-title":"The effect of Syringe-Filling technique on the risk for endophthalmitis after intravitreal injection of Anti-VEGF agents","volume":"245","author":"Finkelstein","year":"2021","journal-title":"Ophthalmologica"},{"issue":"3","key":"10.1016\/j.survophthal.2025.09.025_bib14","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10792-022-02489-x","article-title":"Incidence and visual outcomes of acute endophthalmitis post intravitreal injection of anti-vascular endothelial growth factors in a single referral center","volume":"43","author":"Gonzalez-Gonzalez","year":"2023","journal-title":"Int Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.09.025_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3928\/23258160-20150610-08","article-title":"Current infectious endophthalmitis rates after intravitreal injections of Anti-Vascular endothelial growth factor agents and outcomes of treatment","volume":"46","author":"Gregori","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"10.1016\/j.survophthal.2025.09.025_bib16","volume":"4","author":"Higgins","year":"2023"},{"issue":"8","key":"10.1016\/j.survophthal.2025.09.025_bib17","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/bjo.2007.136069","article-title":"Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide","volume":"92","author":"Jonisch","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.09.025_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000499115","article-title":"Same-Day bilateral intravitreal Anti-Vascular endothelial growth factor injections: experience of a large Canadian retina center","volume":"242","author":"Juncal","year":"2019","journal-title":"Ophthalmologica"},{"issue":"8","key":"10.1016\/j.survophthal.2025.09.025_bib19","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41433-021-01523-z","article-title":"Prefilled eylea syringe: our recent experience","volume":"35","author":"Karatsai","year":"2021","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.survophthal.2025.09.025_bib20","article-title":"Current evidence for the prevention of endophthalmitis in Anti-VEGF intravitreal injections","volume":"2018","author":"Lau","year":"2018","journal-title":"J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2025.09.025_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/24741264231191339","article-title":"Impact of prefilled syringes and masking on postintravitreal injection endophthalmitis","volume":"7","author":"Louis","year":"2023","journal-title":"J Vitreoretina Dis"},{"issue":"4","key":"10.1016\/j.survophthal.2025.09.025_bib22","first-page":"559","article-title":"Incidence of endophthalmitis after intravitreal injections: risk factors, microbiology profile, and clinical outcomes","volume":"26","author":"Mishra","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"24","key":"10.1016\/j.survophthal.2025.09.025_bib23","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1002\/sim.2692","article-title":"A simulation study comparing properties of heterogeneity measures in meta-analyses","volume":"25","author":"Mittlb\u00f6ck","year":"2006","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.survophthal.2025.09.025_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79377-w","article-title":"Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics","volume":"10","author":"Morioka","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.survophthal.2025.09.025_bib25","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1080\/02713683.2021.1874023","article-title":"Endophthalmitis following intravitreal Anti-Vascular endothelial growth factor therapy: changes in incidence and outcomes over a 9-Year period","volume":"46","author":"Pancholy","year":"2021","journal-title":"Curr Eye Res"},{"issue":"4","key":"10.1016\/j.survophthal.2025.09.025_bib26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.survophthal.2019.12.005","article-title":"Prophylaxis measures for postinjection endophthalmitis","volume":"65","author":"Patel","year":"2020","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.09.025_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-056400","article-title":"Development and design validation of a novel network meta-analysis presentation tool for multiple outcomes: a qualitative descriptive study","volume":"12","author":"Phillips","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.survophthal.2025.09.025_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajo.2016.02.028","article-title":"Postinjection endophthalmitis rates and characteristics following intravitreal bevacizumab, ranibizumab, and aflibercept","volume":"165","author":"Rayess","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.09.025_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2288-8-79","article-title":"Undue reliance on I2 in assessing heterogeneity May mislead","volume":"8","author":"R\u00fccker","year":"2008","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.09.025_bib30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2147\/OPTH.S169044","article-title":"Prefilled syringes for intravitreal drug delivery","volume":"13","author":"Sassalos","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.09.025_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2147\/OPTH.S393519","article-title":"Reported rates of intraocular inflammation with intravitreal aflibercept administered via Pre-Filled syringe or from vials in clinical practice between 2012 and 2022","volume":"17","author":"Schmidt-Ott","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.09.025_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ajo.2018.11.023","article-title":"The impact of prefilled syringes on endophthalmitis following intravitreal injection of ranibizumab","volume":"199","author":"Storey","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2025.09.025_bib33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.oret.2024.12.005","article-title":"Endophthalmitis after bilateral Same-Day vs unilateral intravitreal injection","volume":"9","author":"Tao","year":"2024","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2025.09.025_bib34","article-title":"Face masking and risk of Post-Intravitreal injection endophthalmitis: a network Meta-Analysis of 2.6 million injections","author":"Tao","year":"2024","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2025.09.025_bib35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.oret.2023.12.004","article-title":"Endophthalmitis after Anti-VEGF intravitreal injections with aqueous chlorhexidine versus Povidone-Iodine as ocular antiseptics","volume":"8","author":"Ton","year":"2024","journal-title":"Ophthalmol Retin"},{"issue":"10","key":"10.1016\/j.survophthal.2025.09.025_bib36","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jamaophthalmol.2015.2556","article-title":"Association of compounded bevacizumab with postinjection endophthalmitis","volume":"133","author":"VanderBeek","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.09.025_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2022-001188","article-title":"Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)","volume":"7","author":"Wang","year":"2022","journal-title":"BMJ Open Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2025.09.025_bib38","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamapediatrics.2023.3849","article-title":"Probiotics, prebiotics, lactoferrin, and combination products for prevention of mortality and morbidity in preterm infants: a systematic review and network Meta-Analysis","volume":"177","author":"Wang","year":"2023","journal-title":"JAMA Pediatr"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725001845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725001845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:44:32Z","timestamp":1779093872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625725001845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0039625725001845"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.09.025","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prefilled syringes and post-intravitreal injection endophthalmitis: A network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}